Menu

Ocata Therapeutics Inc. OCAT

Full chart Compare
Set alert

Price alert · OCAT

All alert types
8.47 0.00 (+0.00%)

At closeJun 28, 2019, 6:07 PM EDT

8.45 Day range 8.48
3.06 52-week range 8.71

Revenue & Expenses

Other Income → Expenses: $205.61KExpenses → Selling, General & Admin: $11.05MExpenses → Research & Development: $10.53MExpenses → Other Operating Expenses: $13.47MGross Profit → Expenses: $95.44KRevenue → Gross Profit: $95.44KRevenue → Cost of Revenue: $62.44KNet Loss → Expenses: $34.75MOther Income$205.61KGross Profit$95.44KNet Loss$34.75MCost of Revenue$62.44KExpenses$35.05MSelling, General & Admin$11.05MResearch & Development$10.53MOther Operating Expenses$13.47MRevenue$157.88K

Latest period ending Dec 31, 2014 · select a line to chart its full history

OCAT annual income statement
Fiscal yearFY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011FY 2010 Dec 31, 2010
157.88K224.99K466.49K506.42K725.04K
95.44K142.55K349.05K162.47K508.44K
-34.95M-29.71M-25.24M-17.32M-33.59M
-34.75M-31.02M-34.58M-55.19M-54.37M
-1.17-1.34-1.76-3.00-4.00
OCAT annual balance sheet
Fiscal yearFY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011FY 2010 Dec 31, 2010
4.42M1.74M7.24M13.12M15.90M
5.74M3.91M8.50M15.19M19.05M
8.47M26.44M30.04M59.88M41.43M
-2.74M-22.53M-23.14M-46.12M-23.65M
OCAT annual cash flow
Fiscal yearFY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011FY 2010 Dec 31, 2010
-21.45M-21.97M-14.61M-13.63M-8.78M
-263.38K-710.77K-111.35K-36.83K-220.00K
24.39M17.18M8.86M10.88M22.35M
-263.38K-671.83K-96.26K-36.83K-207.40K
2.68M-5.50M-5.86M-2.79M13.35M